MIT Technology Review · May 15, 2025
MIT Technology Review’s The Download on experimental treatments and AI
Markdown · JSON · Original source
On May 15, 2025, MIT Technology Review’s The Download reports on Montana’s bill for experimental treatment clinics, ’s AlphaEvolve, and threats to climate data. The newsletter says the bill allowing clinics to sell unproven treatments passed in Montana. In a closing passage, Jessica Hamzelou argues that anecdotes are overpowering evidence in drug-approval decisions and asks who should decide access to experimental therapies. She says these questions are especially pressing as biotechnology advances and new classes of treatments are created. Will Douglas Heaven describes AlphaEvolve as scoring and iteratively refining code suggestions from Gemini. The newsletter says Google DeepMind’s approach has improved real-world processes, but gives no examples or measurement details here. Casey Crownhart warns that proposed US science-budget cuts could threaten data and tools used to understand climate change, including snowpack monitoring and carbon dioxide measurements. The newsletter does not specify which cuts will take effect or what data may be lost. Its items raise questions about evidence and access in medicine, evaluation of AI-generated solutions, and public data for understanding environmental change.
Headline and summary by Escape Meridian, prepared by Luna from the attributed source. A source check is not independent confirmation of the source’s claims.
Original source
MIT Technology Review · Article
Source details
Original source date: May 15, 2025 (2025-05-15T12:10:00Z).
Date basis: Date from the publisher’s own records, through its API.
Added to Escape Meridian: 2026-11-14T02:53:23.934Z. First observed: 2026-10-30T12:34:21.567Z. Retrieved: 2026-10-30T12:35:46.146Z.
Referenced by
Recorded citations and public file attachments. A reference alone does not establish agreement or influence.
No public references recorded here yet.
Limits
Text as retrieved on October 30, 2026; originally published May 15, 2025. The newsletter links to full stories but the retrieved text does not include them, so it provides limited detail on the bill’s provisions, AlphaEvolve’s reported results, and the potential effects of proposed research cuts. The newsletter describes cuts as proposed and data as potentially threatened; it does not say which cuts will take effect or what data will be lost.
Open question
Who should decide which patients can access experimental therapies, and what evidence should guide that decision?
Source-stated
MIT Technology Review reports that Montana passed a bill allowing clinics to sell unproven treatments, subject to licensing and other conditions described in the newsletter.
A bill that allows clinics to sell unproven treatments has been passed in Montana.
Source-stated
Jessica Hamzelou argues that anecdotes are overpowering evidence in decisions on drug approval and asks who should decide access to experimental therapies.
Anecdotes appear to be overpowering evidence in decisions on drug approval.
Source-stated
Will Douglas Heaven says AlphaEvolve scores and iteratively refines code suggestions from Gemini, and that Google DeepMind reports improvements to real-world processes.
AlphaEvolve scores each of Gemini’s suggestions, throwing out the bad and tweaking the good, in an iterative process
Source-stated
Casey Crownhart warns that proposed US science-budget cuts could threaten climate-related data and tools.
Researchers and civil servants are sounding the alarm that those cuts mean we might lose key data that helps us understand our world and how climate change is affecting it.
Source and contributor context
MIT Technology Review · Publisher
The publisher is identified here. No individual author has been inferred.
Source media
Media retrieval status: unchecked.
Terms and references
Reference context selected by Escape Meridian; separate from source evidence. Entity mentions do not establish authorship, involvement or endorsement.
Google DeepMind
Google DeepMind develops AI systems for general tasks and scientific research, including AlphaFold.
Editorial provenance
Version 1. Publication ID: fdadfab0-e5bf-6abe-dc5a-6957e044428d.
Prepared by openai/gpt-6-luna; grounding review by anthropic/claude-opus-5.5.
Source check: passed by anthropic/claude-opus-5.5 on 2026-11-14T02:48:44.069Z. This checks fidelity to the source, not whether its claims are independently true.
Editorial selection: accept; reasons: bridge_admitted_by_model, second_opinion_categorical.
Observation: 93b746e3b68a7e66d4400d045d776b0583bbf756a654234f61c6c4bfe2172c20. Source text hash: ed934944acb89814fc7a15da8b9570be7c775823fc26c06bc76cf39e759aaac1.
Revision and source-check history
Version 1 · 2026-11-14T02:53:23.934Z
MIT Technology Review’s The Download on experimental treatments and AI
On May 15, 2025, MIT Technology Review’s The Download reports on Montana’s bill for experimental treatment clinics, ’s AlphaEvolve, and threats to climate data. The newsletter says the bill allowing clinics to sell unproven treatments passed in Montana. In a closing passage, Jessica Hamzelou argues that anecdotes are overpowering evidence in drug-approval decisions and asks who should decide access to experimental therapies. She says these questions are especially pressing as biotechnology advances and new classes of treatments are created. Will Douglas Heaven describes AlphaEvolve as scoring and iteratively refining code suggestions from Gemini. The newsletter says Google DeepMind’s approach has improved real-world processes, but gives no examples or measurement details here. Casey Crownhart warns that proposed US science-budget cuts could threaten data and tools used to understand climate change, including snowpack monitoring and carbon dioxide measurements. The newsletter does not specify which cuts will take effect or what data may be lost. Its items raise questions about evidence and access in medicine, evaluation of AI-generated solutions, and public data for understanding environmental change.
Original source
MIT Technology Review · Article
Source details
Original source date: May 15, 2025 (2025-05-15T12:10:00Z).
Date basis: Date from the publisher’s own records, through its API.
Added to Escape Meridian: 2026-11-14T02:53:23.934Z. First observed: 2026-10-30T12:34:21.567Z. Retrieved: 2026-10-30T12:35:46.146Z.
Limits
Text as retrieved on October 30, 2026; originally published May 15, 2025. The newsletter links to full stories but the retrieved text does not include them, so it provides limited detail on the bill’s provisions, AlphaEvolve’s reported results, and the potential effects of proposed research cuts. The newsletter describes cuts as proposed and data as potentially threatened; it does not say which cuts will take effect or what data will be lost.
Open question
Who should decide which patients can access experimental therapies, and what evidence should guide that decision?
Source-stated
MIT Technology Review reports that Montana passed a bill allowing clinics to sell unproven treatments, subject to licensing and other conditions described in the newsletter.
A bill that allows clinics to sell unproven treatments has been passed in Montana.
Source-stated
Jessica Hamzelou argues that anecdotes are overpowering evidence in decisions on drug approval and asks who should decide access to experimental therapies.
Anecdotes appear to be overpowering evidence in decisions on drug approval.
Source-stated
Will Douglas Heaven says AlphaEvolve scores and iteratively refines code suggestions from Gemini, and that Google DeepMind reports improvements to real-world processes.
AlphaEvolve scores each of Gemini’s suggestions, throwing out the bad and tweaking the good, in an iterative process
Source-stated
Casey Crownhart warns that proposed US science-budget cuts could threaten climate-related data and tools.
Researchers and civil servants are sounding the alarm that those cuts mean we might lose key data that helps us understand our world and how climate change is affecting it.
Source and contributor context
MIT Technology Review · Publisher
The publisher is identified here. No individual author has been inferred.
Source media
Media retrieval status: unchecked.
Terms and references
Reference context selected by Escape Meridian; separate from source evidence. Entity mentions do not establish authorship, involvement or endorsement.
Google DeepMind
Google DeepMind develops AI systems for general tasks and scientific research, including AlphaFold.
Editorial provenance
Version 1. Publication ID: fdadfab0-e5bf-6abe-dc5a-6957e044428d.
Prepared by openai/gpt-6-luna; grounding review by anthropic/claude-opus-5.5.
Source check: passed by anthropic/claude-opus-5.5 on 2026-11-14T02:48:44.069Z. This checks fidelity to the source, not whether its claims are independently true.
Editorial selection: accept; reasons: bridge_admitted_by_model, second_opinion_categorical.
Observation: 93b746e3b68a7e66d4400d045d776b0583bbf756a654234f61c6c4bfe2172c20. Source text hash: ed934944acb89814fc7a15da8b9570be7c775823fc26c06bc76cf39e759aaac1.
passed · 2026-11-14T02:48:44.069Z · anthropic/claude-opus-5.5
Publication: fdadfab0-e5bf-6abe-dc5a-6957e044428d
attribution — pass: This is one newsletter issue with staff-written blurbs, not a bare listing. The items are attributed correctly: Hamzelou wrote the Montana item and the closing essay, Heaven the AlphaEvolve item, and Crownhart the climate-data item. Claims stay attributed to the newsletter or its authors.
This is today's edition of The Download, our weekday newsletter
summary — pass: The reading leads with the main items and identifies the actors. It explains AlphaEvolve in plain terms and keeps Hamzelou's argument. Gemini is not explained, but context makes clear it is an AI model whose code suggestions are scored. The summary says the bill passed without noting that it still needed the governor's signature, as the source states. This is a small omission, not a contradiction. The question follows directly from Hamzelou's essay.
Once it’s signed by the governor, the law will be the most expansive in the country
date — pass: May 15, 2025 matches the UTC day of originalPublished. dateModified (11:35Z) precedes publication, so there was no later edit. The Deep Dive sidebar mentions later items, such as OpenAI's math findings, but the reading neither uses nor relies on them. The proposed cuts are described as proposed, not as outcomes. This is a publisher page, so no archive disclosure is needed.
support — pass: Each claim matches its excerpt. The AlphaEvolve real-world-improvement claim rests on the newsletter's statement and is not presented as independently verified. The reading correctly notes that the item gives no examples or measurements. The climate-cut claims are kept conditional and match the source's wording.
the firm has shown that its approach can not only tackle unsolved theoretical puzzles, but improve a range of important real-world processes as well
media — pass: No media was selected and none was supplied or verified, so there is nothing to misidentify.
Challenge or correct this reading
Send a correction or an opposing source with this reading’s URL. Disagreement and uncertainty can remain unresolved.
Google DeepMind develops AI systems for general tasks and scientific research, including AlphaFold.
Explore Google DeepMindGoogle DeepMind develops AI systems for general tasks and scientific research, including AlphaFold.
Explore Google DeepMind